New female contraceptive under development: end-user preferences revealed in web-based survey

FHS
July 26, 2023
9:01 am

Researchers investigated prospective end-user preferences for an on-demand, non-hormonal female contraception.

Supreme Court Doesn’t Seem Convinced FDA Was Unfair in Blocking Flavored Vapes

A majority of Supreme Court justices didn’t seem convinced Monday that federal regulators misled companies before refusing to allow them to sell sweet-flavored vaping products

December 4, 2024

BioNTech expects up to $950M in Covid vaccine write-offs after Pfizer lowers expectations

Pfizer’s write-offs for its Covid-19 vaccine are having a ripple effect on partner BioNTech, which is expecting to write off up to €900 million ($950

October 17, 2023

PharmaTher Announces FDA Acceptance, As a Priority Original Abbreviated New Drug Application, for KETARX™ (Ketamine) | Psychedelic Invest

FDA assigns GDUFA goal date of April 29, 2024 Milestone builds upon PharmaTher’s commitment toward unlocking the potential of ketamine for unmet medical needs PharmaTher

September 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.